Publication | Closed Access

SP100030 is a novel T-cell-specific transcription factor inhibitor that possesses immunosuppressive activity in vivo.

Clinical ImmunologyImmunosuppressive ActivityImmune RegulationImmunologyImmunologic MechanismAutoimmunityT Cell ImmunityImmunosuppressionCellular Immune ResponseMedicineCell BiologyCell Signaling